Abstract
THU-185 - A prospective, pragmatic post-authorisation safety study of early recurrence of hepatocellular carcinoma in hepatitis C virus-infected patients after direct-acting antiviral (DAA) therapy: DAA-PASS
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have